Studies have shown that long-term serum TC deficiency can activate nuclear factor κB, a key transcription factor involved in regulating immunity, inflammation, apoptosis, carcinogenesis, and other processes (310) Additionally, low serum TC levels may deplete CD8+ T cells in the tumor microenvironment, weakening the immune system’s protective function (311, 312). This evidence concerns the gene CD8A and neoplasm.